Health economic decision-making: a comparison between UK and Spain
- PMID: 22833571
- DOI: 10.1093/bmb/lds017
Health economic decision-making: a comparison between UK and Spain
Abstract
Objective: This review examines the impact of economic evaluation in informing national or local policies within both jurisdictions. We focus on the factors that have made the economic evaluation evolves differently in both settings.
Areas of agreement: Economic evaluation facilitates decision-making regarding the efficiency of interventions. The existence of national or local bodies regulating the process has contributed to increasing its use in decision-making and the development of its methods.
Areas of controversy: Cost-effectiveness approach is based on the assumption of health maximization subject to a budget constraint. Decision-makers are not only interested in health maximization alone. This may result in policy-makers failing to consider economic evaluations into their allocation decisions. AREAS TO DEVELOP RESEARCH: Methods that incorporate wider decision-makers goals (mainly local) and research to study the real impact of economic evaluation in terms of improved efficiency and equity are particularly required.
Similar articles
-
Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.Value Health. 2002 Mar-Apr;5(2):71-8. doi: 10.1046/j.1524-4733.2002.52109.x. Value Health. 2002. PMID: 11918822
-
The use of economic evaluations in NHS decision-making: a review and empirical investigation.Health Technol Assess. 2008 Apr;12(7):iii, ix-x, 1-175. doi: 10.3310/hta12070. Health Technol Assess. 2008. PMID: 18373906
-
Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.Value Health. 2014 Jan-Feb;17(1):5-14. doi: 10.1016/j.jval.2013.08.2291. Epub 2013 Dec 13. Value Health. 2014. PMID: 24438712
-
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.Value Health. 2007 Sep-Oct;10(5):336-47. doi: 10.1111/j.1524-4733.2007.00187.x. Value Health. 2007. PMID: 17888098
-
Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake.Appl Health Econ Health Policy. 2015 Jun;13(3):303-9. doi: 10.1007/s40258-014-0132-7. Appl Health Econ Health Policy. 2015. PMID: 25288052 Review.
Cited by
-
Immuno-Oncology Medicines: Policy Implications and Economic Considerations.Innov Pharm. 2019 Aug 8;10(3):10.24926/iip.v10i3.1799. doi: 10.24926/iip.v10i3.1799. eCollection 2019. Innov Pharm. 2019. PMID: 34007565 Free PMC article. Review.
-
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.Eur J Health Econ. 2018 Jan;19(1):123-152. doi: 10.1007/s10198-017-0871-0. Epub 2017 Mar 16. Eur J Health Econ. 2018. PMID: 28303438 Free PMC article.
-
Commissioning [Integrated] Care in England: An Analysis of the Current Decision Context.Int J Integr Care. 2022 Oct 7;22(4):3. doi: 10.5334/ijic.6693. eCollection 2022 Oct-Dec. Int J Integr Care. 2022. PMID: 36304783 Free PMC article.
-
AOTMiT reimbursement recommendations compared to other HTA agencies.Eur J Health Econ. 2024 Nov;25(8):1291-1310. doi: 10.1007/s10198-023-01655-x. Epub 2024 Jan 23. Eur J Health Econ. 2024. PMID: 38261131 Free PMC article.
-
Does the approach to economic evaluation in health care depend on culture, values, and institutional context?Eur J Health Econ. 2018 Jul;19(6):769-774. doi: 10.1007/s10198-017-0943-1. Eur J Health Econ. 2018. PMID: 29209854 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials